On August 5, the U.S. Department of Justice (DOJ) announced that a federal grand jury in the District of Nevada returned a six-count indictment charging Stephen Dubin, M.D., of Henderson, Nevada, with conspiracy to commit healthcare fraud and five
Inside the False Claims Act
Inside the False Claims Act, published by Bass, Berry & Sims PLC, focuses on legal developments and enforcement trends related to the False Claims Act (FCA). The blog covers topics such as healthcare fraud, procurement fraud, government investigations, whistleblower litigation, and regulatory compliance. It provides analysis of significant FCA settlements, court rulings, and government enforcement initiatives, including issues involving Medicare, Medicaid, and federal contracting. The blog also addresses related statutes like the Anti-Kickback Statute and the Eliminating Kickbacks in Recovery Act, offering insights into risk mitigation and defense strategies for companies and healthcare providers subject to FCA scrutiny.
Latest from Inside the False Claims Act - Page 2
DOJ’s $6.5 Billion National Health Care Fraud Takedown Signals a New Era of Data-Driven Enforcement
The Department of Justice (DOJ) recently announced the largest National Health Care Fraud Takedown in its history, charging 455 defendants—including 90 physicians and other licensed medical professionals—in schemes involving more than $6.5 billion in alleged false claims.…
Smoke is Not Fire: Fourth Circuit Rejects Stark and AKS Theories Built on Ordinary Business Practices and Conclusory Allegations
It is not every day that an 83-page qui tam complaint alleging Stark Law and Anti-Kickback Statute (AKS) violations is dismissed at the pleading stage, particularly when filed by experienced relator’s counsel and accompanied by more than 30 pages of…
Procurement Fraud Enforcement Trends Continue Into 2026
Legal Hurdles in Using FCA to Challenge DEI Programs
In a recent article for Law360, I examined the significant challenges the Department of Justice (DOJ) may face as it seeks to use the False Claims Act (FCA) to pursue allegedly unlawful diversity, equity, and inclusion (DEI) practices.…
Federal Court Seizes $2 Million from Wound Care Clinic: What Providers, Distributors, and Manufacturers Need to Know
Skin substitutes, bioengineered or natural materials designed to promote healing by replacing or supporting damaged skin, have become a key component of advanced wound care. But the significant Medicare reimbursement of these products commanded over the last few years has…
Takeaways from IBM’s DEI Settlement
I provided insight for Law360 on the government’s recent settlement with IBM to settle allegations into the company’s diversity, equity and inclusion (DEI) practices. The IBM deal is the first of its kind involving a company and alleged violations of…
Understanding the False Claims Act Implications of Trump’s Latest DEI Order for Federal Contractors
I recently shared my perspective on President Trump’s newest executive order, which is designed to restrict federal contractors from participating in what the administration characterizes as “racially discriminatory” DEI efforts. Under this order, certain DEI‑related activities could put a contractor’s…
Pending Circuit Court Case Concerning the Constitutionality of the FCA’s Whistleblower Provisions
I was quoted in an article published by McKnight’s Long-Term Care News examining the Eleventh Circuit’s pending decision in United States ex rel. Zafirov v. Florida Medical Associates that could determine whether the False Claims Act’s (FCA) whistleblower (qui tam) provisions are…
Genetic Testing Fraud: Why CMS and DOJ Are Increasing Scrutiny
In 2025, the Department of Justice’s National Health Care Fraud Takedown led to criminal charges against 324 defendants and $14.6 billion in intended losses.…
